Nature of the T Lymphocytes in Lymphocyte Predominance Hodgkin's Disease

References

• Rosenthal S. R. Significance of tissue lymphocytes in prognosis of lymphogranulomatosis. Arch. Pathol. 1936; 21: 628–646
   Google Scholar
• Jackson H. The classification and prognosis of Hodgkin's disease and allied disorders. Surg. Gynecol. Obstet. 1937; 64: 465–467
   Google Scholar
• Jackson H., Parker F. Hodgkin's disease-II. Pathology. New Engl. J. Med. 1944; 231, 35–44
   Google Scholar
• Jackson H., Parker F. Hodgkin's Disease and Allied Disorders. Oxford University Press, New York N Y 1947
   Google Scholar
• Wright C. J. E. The ‘benign’ form of Hodgkin's disease (Hodgkin's paragranuloma). J. Pathol. Bacteriol. 1960; 80: 157–171
   PubMedGoogle Scholar
• Dawson P. J., Harrison C. V. A clinicopathological study of benign Hodgkin's disease. J. Clin. Pathol. 1961; 14: 219–231
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966; 26: 1063–1081
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Craver L. F., Hall T. C., Rappaport H., Ruben P. Report of the Nomenclature Committee. Cancer Res. 1966; 26: 1311
   Web of Science ®Google Scholar
• Mason D. Y., Banks P. M., Chan J. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am. J. Surg. Pathol. 1994; 18: 526–530
   PubMed Web of Science ®Google Scholar
• Dargent J. L., Schandené L., Kornreich A. TH1-type immune response in lymphocyte-predominance Hodgkin's disease [Letter]. Br. J. Haematol. 1995; 91: 775–776
   PubMed Web of Science ®Google Scholar
• Naish S. J. Handbook: immunohistochemical staining methods. Dako, Carpinteria, CA 1989
   Google Scholar
• Ausubel F. M., Brent R., Kingston R. E. Current Protocols in Molecular Biology. Greene Publishing Associated and Wiley-Interscience, New-York 1989
   Google Scholar
• Cleary M. L., Chao J., Warnke R., Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc. Natl. Acad. Sci. USA 1984; 81: 593–597
   PubMed Web of Science ®Google Scholar
• Yoshikai F. M., Anatoniou D., Clark K. Sequence and expression of transcripts of the human T-cell receptor β-chain genes. Nature 1984; 312: 521–524
   PubMed Web of Science ®Google Scholar
• Lespagnard L., Cochaux P., Larsimont D., Degeyter M., Velu T., Heimann R. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping. in situ hybridization and polymerase chain reaction. Am. J. Clin. Pathol. 1995; 103: 449–452
   PubMed Web of Science ®Google Scholar
• Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 1989; 169: 2191–2198
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H. A revised european-american classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Romagnani S. Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?. Immunology Today 1992; 13: 379–381
   PubMedGoogle Scholar
• Mossmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996; 17: 138–146
   PubMedGoogle Scholar
• Cogan E., Schandené L., Crusiaux A., Cochaux P., Velu T., Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N. Engl. J. Med. 1994; 330: 535–538
   PubMed Web of Science ®Google Scholar
• Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab. Invest. 1986; 54: 457–461
   PubMed Web of Science ®Google Scholar
• Poppema S. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am. J. Pathol. 1989; 135: 351–357
   PubMed Web of Science ®Google Scholar
• Poppema S. Lymphocyte-predominance Hodgkin's disease. Semin. Diagn. Pathol. 1992; 9: 265–271
   PubMed Web of Science ®Google Scholar
• Hansmann M. L., Fellbaum C., Hui P. K., Zwingers T. Correlation of content of B cells and Leu-7 positive cells with subtype and stage in lymphocyte predominance type Hodgkin's disease. J. Cancer Res. Clin. Oncol. 1988; 114: 405–410
   PubMed Web of Science ®Google Scholar
• Hansmann M. L., Stein H., Dallenbach F., Fellbaum C. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type. Am. J. Pathol. 1991; 138: 29–36
   PubMed Web of Science ®Google Scholar
• Kamel O. W., Gelb A. B., Shibuya R. B., Warnke R. A. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease. T-cell rich B-cell lymphoma and follicular lymphoma. Am. J. Pathol. 1993; 142: 541–546
   PubMed Web of Science ®Google Scholar
• Bowen M. B., Butch A. W., Parvin C. A., Levine A., Nahm M. H. Germinal center T cells are distinct helper-inducer T cells. Hum. Immunol. 1991; 31: 67–75
   PubMed Web of Science ®Google Scholar
• Delabie J., Ceuppens J. L., Vandenberghe P., de Boer M., Coorevits L., De Wolf-Peeters C. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 1993; 82: 2845–2852
   PubMed Web of Science ®Google Scholar
• Sappino A. P., Seelentag W., Pelte M. F., Alberto P., Vassalli P. Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients. Blood 1990; 75: 958–962
   PubMed Web of Science ®Google Scholar
• Dolcetti R., Frisan T., Sjöherg J. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Cancer Res. 1995; 54: 3675–3681
   Google Scholar
• Munro J. M., Freedman A. S., Aster J. C. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease. Blood 1994; 83: 793–798
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Waldron J. W., Hsu P. L., Hough A. J. Cytokines in malignant lymphomas: review and prospective evaluation. Hum. Pathol. 1993; 24: 1040–1057
   PubMed Web of Science ®Google Scholar
• Macon W. R., Cousar J. B., Waldron J. A., Hsu S. M. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas. Am. J. Pathol. 1992; 141: 1031–1036
   PubMed Web of Science ®Google Scholar
• Thomson C. B., Lindsten T., Ledbetter J. A. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 1989; 86: 1333–1337
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Grass H. J., Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am. J. Pathol. 1995; 147: 912–922
   PubMed Web of Science ®Google Scholar
• Schwaller J., Tobler A., Niklaus G., Hurwitz N., Hennig I., Fey M. F., Borisch B. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood 1995; 85: 2182–2188
   PubMed Web of Science ®Google Scholar